The Lancet Oncology Commission: Future Cancer Research Priorities in the USA — Part 1
The Lancet Oncology Commission: Future Cancer Research Priorities in the USA — Part 2
Top scientists discuss how they recommend expanding and implementing the Blue Ribbon Panel’s road map for cancer research. They’ll discuss a report that will be published by the journal The Lancet Oncology and is co-edited by Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, and Chi Van Dang, M.D., Ph.D., scientific director at Ludwig Cancer Research and professor at The Wistar Institute.
Visit Johns Hopkins inHealth at: https://www.hopkinsmedicine.org/inhealth